FIGURE 3.

Weighted KM curves for FL time to next treatment or death. (1) In addition to the weighted adjustment, Cox proportional hazards model was further adjusted for age, race, ethnicity, and index year. (2) Non‐parametric bootstrap procedures with 500 replications were used to calculate 95% CIs and p‐values. (3) The proportions displayed were calculated prior to the rounding and may be slightly different than if they were calculated based on rounded numbers. CI, confidence interval; DRd, daratumumab, lenalidomide, and dexamethasone; FL, front‐line; KM, Kaplan–Meier; VRd, bortezomib, lenalidomide, and dexamethasone.